Advocacy: Shaping cancer care through survivorship—and politics

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Cancer advocacy in the spotlight

This September, the Cancer History Project is focusing on the evolution of cancer advocacy over the past 50 years. Here are selected archives recognizing and celebrating advocates—and remembering their legacy.

For years cancer researchers looked wistfully at the appropriations hauled in by the politicized AIDS activists. What would happen if cancer patients became as politicized? Would more money suddenly be found for cancer?

Now the time for wondering has passed.

Like it or not, breast cancer patients have moved beyond battling paternalistic surgeons. Politicized and militant, they are taking on Congress, the President and NCI.

Excerpted from Judith L. Pearson’s new book, From Shadows to Life: A Biography of the Cancer Survivorship Movement.

This evaluation centers on the impact of the National Breast Cancer Coalition’s (NBCC) research and advocacy programs and efforts, with an emphasis on NBCC’s work after NBCC announced the Breast Cancer Deadline 2020 in 2010.


Quote of the week

We will no longer be passive. We will no longer be polite. We can no longer afford to wait while Congress gets around to significant, decent funding for breast cancer.

Fran Visco

Featured contributors in cancer advocacy

National Breast Cancer Coalition

National Coalition for Cancer Survivorship


Celebrating advocates


Recent contributions


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login